Pharmapotheca A
The Company With A Purpose for the Novel Treatment of ADHD
- Stage Prototype Ready
- Industry Biotechnology
- Location Delmar, NY, US
- Currency USD
- Founded November 2014
- Employees 2
- Incorporation Type LLC
- Website pharmapotheca.com
Company Summary
Pharmapotheca A, LLC (the “Company”) is a New York based pharmaceutical development company formed in 2014 that is positioning itself to become a disruptive and significant player in the highly regulated, government controlled, supply chain for pharmaceutical agents used in the manufacture of amphetamines for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Two US Patents for the process and compounds have been issued.
Team
-
President and TreasurerA dynamic, 30-year veteran of the global pharmaceutical industry with broad experience in both the large pharmaceutical and the entrepreneurial work environments. An expert organic process development chemist. An inventor on fourteen issued US Patents and extensively published in the peer reviewed, scientific literature. Over twenty years’ direct experience in operating and globally managing chemical laboratory/pilot plant facilities.
-
VP and SecretaryMuch experience in developing novel formulations of proprietary and generic human drugs while working at Stiefel Laboratories (Oak Hill, NY) and Sterling Drug (Rensselaer, NY). Has detailed knowledge of developing patent claims that will protect the company's IP.
-
CFOTom has been working with Pharmapotheca A since July 2015. Since August of 2008, Tom has provided contract-based CFO and transaction advisory services on behalf of Scale Finance LLC to multiple clients in various industries including biotech, medical device, health care services, and molecular diagnostics, among others. He is the firm's lead life sciences partner and was named a 'Top CFO' in the Triangle by Business Leader Media in 2010.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.